Dr. Peter Mogayzel
Dr. Peter Mogayzel is the Director of the Cystic Fibrosis Center and Medical Director of the Pediatric Specialty Clinic at the Johns Hopkins Hospital. A Professor of Pediatrics at the Johns Hopkins School of Medicine, he attended Brown University and received his M.D. and Ph.D. degrees from Boston University. He received a M.B.A. at Johns Hopkins University in 2010. He completed his pediatric residency at the University of Washington, and pediatric pulmonary and pediatric critical care fellowships at Johns Hopkins in 1998 before joining the faculty. Dr. Mogayzel is a Fellow of American College of Chest Physicians and the American Academy of Pediatrics. His research interests include the regulatory properties of the CFTR gene, mucociliary clearance and development of new therapeutics for cystic fibrosis. Dr. Mogayzel served as Chairman of the Clinical Practice Guidelines for Pulmonary Therapies Committee and the Therapeutic Development Network Protocol Review Committee both of the Cystic Fibrosis Foundation. He is also a past Chairman of the Cystic Fibrosis Foundation Center Committee which accredits cystic fibrosis centers in the US.
Prof. Isabelle Sermet-Gaudelus
Isabelle Sermet-Gaudelus is a professor in Paediatric at the Necker-Enfants Malades Hospital, Paris France. She graduated from the University Paul Sabatier, Toulouse in 1990 and undertook clinical trainings in Paediatrics in Paris. She is now the head of the paediatric Cystic Fibrosis center, at the Necker-Enfants Malades Hospital. She is involved in the European Clinical Trial Network as head of the standardization committee. She has been or is the principal investigator of a number of clinical trials in CF, largely involving novel small-molecules directed at CFTR function. She has been engaged for several years in a programme of phenotype-genotype studies, using different epithelial electrophysiological measurements and search for severity biomarkers. She is now co-heading with Aleksander Edelman a research group and is more particularly involved in functional studies based on investigations for proteins interacting with CFTR and modulating its function and search for molecules modifying these interactions.